SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-043694
Filing Date
2023-04-10
Accepted
2023-04-10 18:20:14
Documents
1
Period of Report
2023-04-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2312272-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2312272-1_4seq1.xml 4 8942
  Complete submission text file 0001104659-23-043694.txt   10269
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 228 VILLAGE POND ROAD GUILFORD CT 06437
Business Address
Nandabalan Krishnan (Reporting) CIK: 0001733387 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 23812018